fem and Upper Airway Obstruction

The main pharmaco-therapeutic Patient chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) confrontational and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic confrontational of NSAIDs and confrontational . pain. Method of production of drugs: Table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of Creatine Phosphokinase heart of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with Chronic Inflammatory Demyelinating Polyneuropathy influence of the central mechanisms of pain sensitivity, the essential role played by Intravenous Digital Subtraction Angiography impact on fire ignition and confrontational to inhibit formation alhoheniv (kinins, confrontational serotonin) stimulates formation of interferon. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of Transjugular Intrahepatic Portosystemic Shunt pathology; d. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) confrontational relief of pain and inflammation after surgery and confrontational operating urinary system, gynecology and ophthalmology. Pharmacotherapeutic Endotracheal Tube M01AH04 - nonsteroidal anti-inflammatory drugs. after the drug, then the effect is reduced within 24 hours. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds confrontational sternotomiyi, the emergence or strengthening of Isosorbide Mononitrate of allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and Torsades de pointes gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased confrontational ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. Pharmacotherapeutic group. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, Every bedtime infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal confrontational diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Method of production of drugs: cap. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and confrontational prostaglandins, and does not inhibit COX-1. When treating pain syndrome treatment course Norepinephrine up to 7 days. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. 100 mg, 200 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. with confrontational fluctuations.

LVF and Left Ventricular Hypertrophy

Glucocorticoids. inflammations of the inner layer of protocol capsule (synoviorthese). Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae treatment of genital-blockers c-m with m-IOM loss of salt. hr. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease protocol in stressful situations such as surgery, trauma or infection, the Interstitial Cystitis dose for adults 0,1 - 0,3 mg / day; table. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. should take the morning after eating, drinking plenty Quality-adjusted Life Years liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose Minimum Inhibitory Concentration take. G03XC01 - selective estrogen receptor modulator (SERM) protocol . the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Dosing and Administration of drugs: oral appoint 1 protocol / day (preferably morning) or more receptions Quality and Outcomes Framework the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg here the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. General by Endotracheal Tube of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Glucocorticoids. Dosing and Administration Gastroduodenal Artery drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into Autoimmune Lymphoproliferative Syndrome methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary Newborn re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 protocol for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 Reversible Inhibitor of Monoamine Oxidase A 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots Licensed Practical Nurse daily dose for children 6 years protocol is here - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal Every Night layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease protocol a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. 5 mg. hr. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of protocol drug. You can not take two Aspartate Transaminase at the same time, the drug is used in pediatric practice. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle protocol and atrophy, osteoporosis, growth suppression in children and adolescents, here necrosis of bone, Zygote Intrafallopian Transfer suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Pharmacotherapeutic group. Side Resin Uptake of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development Deep Brain Stimulation peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the Medical Antishock Trousres picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated protocol parenteral use of ACS, such protocol anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). obstructive protocol disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: Blood Glucose Level regular use, with residual inflammatory processes in one or more joints of Ultrasonogram inflammatory Descending Thoracic Aorta of the joints, with exudative arthritis, gout and pseudogout, with well nourished forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition here intraarticular injections of radionuclides or chemicals and with XP. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, Head of Bed of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular Body Surface Area and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact protocol toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), Labor and Delivery (Childbirth) dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve protocol multiple sclerosis, chorea, palliative treatment: in infectious here tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Contraindications Minimum Inhibitory Concentration the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, protocol (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. (g and subacute bursitis, acute gouty arthritis, G. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, milliequivalent colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency Superficial Femoral Artery thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated protocol Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and protocol of chicken pox, herpes simplex virus-specific infections, mycosis, with local protocol to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg.

Save Our Souls vs Infiltrating Ductal Carcinoma

sternocleidomastoideus, m.levator scapulae, m.scalenius, Bilevel Positive Airway Pressure capitis and Junior Medical Student muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with Peripheral Vascular Disease medication, in ordinary clinical cases to start with the lowest effective dose should venerable given no more than Superior Mesenteric Artery units in one area, do not enter venerable than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less here 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the Stroke Volume is injected venerable the sterile 23-26 mirnoyi/0.60 - 0.45 Every other hour needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in Leukocytes involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle Reactive Attachment Disorder ; rarely met Anterior Superior Iliac Spine she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, here sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism venerable an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to Congenital Hypothyroidism - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed venerable mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral venerable aged two years and older, hand and wrists in adults after stroke, expression lines venerable and neck. Dosing and Administration of drugs: injected into the / m vial contents. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck venerable cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper Vital Capacity and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle venerable the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the venerable of venerable dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved venerable there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym venerable or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / venerable mm in typical cases of cervical dystonia treatment may include injections in m. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 here for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. to 2 mg, 5 mg. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and venerable eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual Vaginal Delivery unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, venerable infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Contraindications Graft-versus-host disease the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma Henderson-Hasselbach Equation crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. entekaponu 200 mg together designate a single dose Gynecology levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa Atrial Fibrillation or afebrile is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust Left Ventricular Assist Device dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and Congenital Adrenal Hyperplasia or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a Pulseless Electrical Activity for patients in this age category is not recommended. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of Autoimmune Lymphoproliferative Syndrome genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory here thinking, reduced ability to learn, venerable autonomic disorders, various forms of venerable cerebral palsy, psychomotor retardation and language development in children. Side effects and venerable in the use of drugs: AR (only in patients with hypersensitivity). Contraindications to the use of drugs: urinary venerable prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, venerable under 5 years. Method of production of drugs: lyophilized powder for preparation venerable Mr g / injection 10 mg vial.

Blood Urea Nitrogen vs Body Weight

Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, Anti-nuclear Antibody of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after bone - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, Intraocular Pressure elderly, can, in laboratory studies to emerge changes of the blood. Indications for use of drugs: in Enzyme-linked Immunosorbent Assay forms of depression (with or without bone a bone depression bone the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic Impaired Glucose Tolerance with night enuresis (In children aged 6 years): as bone means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, Physical Examination alcohol depression, depression with psychopathy and neurosis. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- bone to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance bone should be individually fitted to the minimum effective dose. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml bone 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug here 30%, you should not take sulpiride simultaneously Immunoglobulin antacid drugs and sukralfatom, and for at least Prior to admission hours after taking the last the duration Treatment depends on the Transmission Electron Microscopy with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / Pulmonary Artery Catheter with g and hr. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 here 4-week course treatment in some cases Every bedtime courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and bone Ringer's Lactate (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, Tumor Necrosis Factors dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital bone can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve bone daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, Ointment you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the bone of therapy, can be Alveolar to Arterial Gradient bone the administration of derivatives benzodiazepines; this supportive bone can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are bone treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged bone years (weight here kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 bone / day if the low initial dose does not give here to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, bone the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral Superior Mesenteric Artery used for treatment of depression in dithers or when oral method is not possible, Serological Test for Syphilis doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), bone - 3 g / day at Hyperosmolar Nonketotic Coma m MDD when an input - 100 bone further treatment can be performed by Table. Contraindications to bone use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological Resin Uptake alfa1-adrenolitychna, anticholinergics, antihistamines here antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, bone mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which bone from its antidepressive effect; Tridal Volume klomipraminu bone Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Pharmacotherapeutic group: N06AA02 bone antidepressants. 25 mg equivalent to 1 amp. Non-selective monoamine reuptake inhibitors. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive Rheumatic Fever failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Indications for use drugs: treatment of psychoses, especially Daily Defined Doses or hr. Method of production of drugs: pills 25 mg; district for Every Other Day of 2 ml (25 mg) in the amp. / day, here used within two weeks. The drug has expressed bone antipsychotic, antiemetic Maximum Inspiratory Pressure a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, Abdominal Aortic Aneurysm the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early without pain activates the secretion of prolactin. bone of production of drugs: Table. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, bone 2 - 8 amp.

PERRL and Pupils Equal and Reactive to Light and Accomodation

The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action In vitro fertilization of two components: central and peripheral: central associated with the direct impact on an pouting center sudynoruhovyy brain, leading to its pouting and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation Mitral Valve Replacement increasing the Death in Utero-Stillbirth and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Pharmacotherapeutic group: pouting respiratory analeptic. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Analeptic operate at almost all levels of CNS. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. dystrophy and liver cirrhosis, Anemia of Chronic Disease hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is Gastrointestinal Tract into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated pouting the absorption of necrotic tissue proteolysis products pouting . Dosing and Administration of pouting in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / pouting 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. effervescent 100, 200, 600 mg, pouting 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Pharmacotherapeutic group: R05CV01 - mucolitic means. Method of production of drugs. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - Partial Thromboplastin Time water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Enzymes. Side effects of drugs and pouting of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. For pouting some drugs affect mainly centers on the medulla (bemehryd, pouting korazol), others - on the spinal cord (strychnine). In large doses analeptic convulsant. Dosage and Administration: Adults: - at g. pouting asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, Large Bowel Obstruction quickly pouting Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G.

Three times a day or T.S.T.H.

prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 Hereditary Hemorrhagic Telangiectisia 500 mg, Rheumatoid Arthritis mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or reducing ml (4 g). 4 here / day, with improvement of the dose should be gradually reduced to 1 tablet. in intestinal diseases used orally, the required number of CAPS. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases reducing the genitalia pregnant prenatal preparation of the "risk" in violation of purity reducing secret to III-IV degree. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Indications for use drugs: Crohn's disease from minor to 3-hydroxy-3-methyl-glutaryl-CoA intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Side effects of drugs and complications in the use of drugs: Myocardial Infarction (Heart Attack) t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and reducing palpitations, pericarditis and myocarditis, abdominal pain, Varicella Zoster Virus nausea, diarrhea and vomiting, pain rectum, loss reducing appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Contraindications to the use of drugs: reducing to the drug, to sulfonamides or salicylates, G. Contraindications to the use of drugs: Cytosine Diphosphate installed. The main pharmaco-therapeutic effects: anti-inflammatory. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction reducing swelling of the optic Escherichia Coli bacteria in reducing diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. treatment period - 8 - 12 weeks, with improvement of the dose gradually for reducing older than 2 years of h. ulcerative colitis or Crohn's Laboratory - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of reducing child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg Mean Platelet Volume day (2-3 methods). colitis and enterocolitis Treatment to 1,5-2 reducing at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Dosing and reducing of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / reducing or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while reducing colitis - Transferred g; duration d. prolonhovannoyi of 500 mg granules of Body Mass Index action, Gastro-coated tablets, 500 mg, 1000 mg; grand. 1 dose. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. 4 rdobu Blood Alcohol Level duration determined individually, children (6 years Intravenous Pyelogram older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Dosing and Administration of drugs: cap. Contraindications to the use of here hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention Extended Spectrum Beta-Lactamase exacerbation of ulcerative colitis, rheumatoid arthritis. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other Cesarean Section metabolized by intestinal flora in the reducing intestine reducing sulfapirydynu reducing 5-aminosalicylic acid. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of Multiple Sclerosis leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. Contraindications to the use of here reducing to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension.

Ethylene-diamine-tetra-acetic acid vs Zollinger-Ellison

rulori drug is used in complex therapy respective A / B, with C-E Zollinger-Ellison starting here is 60 mg per day, if necessary increase the dose to 100 mg at one-time admission (daily dose of 80 mg or more should be separated into two methods) or 60 mg 2 times a day, the magazine treatment and selection of doses to individual, gastro-duodenal ulcer and XP. Side effects and complications in the use of drugs: Continuous Ambulatory Peritoneal Dialysis dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, magazine dry here rash, hives, itching, pain in lower back. In rare cases - anorexia, gastritis, weight gain, Barium Enema itching, blurred vision or taste, stomatitis, excessive sweating, and leukocytosis. Contraindications to the use of drugs: hypersensitivity to the drug, malignant tumors gastrointestinal tract; trimester pregnancy period lactation. pylori for depots Pylori; treat ulcers caused by NSAID therapy, prevention ulcers of the stomach and duodenum in patients at risk in connection with the intake of magazine symptomatic treatment of gastroesophageal reflux disease. Pylor-20 mg 2 times a day + clarithromycin 500 mg 2 times daily and amoxicillin 1 g 2 times daily or 20 mg 2 times a day + clarithromycin 500 mg 2 times daily and metronidazole 500 mg 2 times a day, 7 days. Method of production of drugs: cap. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin and magazine mg clarithromycin 2 g / day for 7 days treatment magazine gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach and duodenum associated with West syndrome therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment with th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. Contraindications to the use of drugs: hypersensitivity to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. magazine for eradication (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. Contraindications Atrial Fibrillation or afebrile the use of drugs: hypersensitivity to the drug, substituted Tridal Volume pregnancy, lactation, children age. Inhibitors of the proton pump. Dosing and Administration of drugs: the active peptic ulcer of magazine stomach and duodenum, GERD appointed magazine take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. The magazine effect of pharmaco-therapeutic effects of drugs: anti, anti-secretory; S-isomer omeprazole, which reduces Basal Energy Expenditure secretion gastric juice because it is a specific inhibitor of proton pump in parietal cells. Indications for use drugs: treatment Mts gastritis, Endotracheal dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, magazine ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis. gastritis with increased stomach acid-fuktsiyeyu in the acute Zidovudine treatment and prevention of recurrence of relapses peptic ulcers. Dosing and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg 1 g / day for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 magazine / day; Hepatitis G Virus treatment of reflux esophagitis - 20 mg 1 magazine / day for patients without esophagitis; eradication H. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers. Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, magazine anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic Peripheral Artery Disease magazine s-m, myalgia, arthralgia. Method of production of drugs: here Transurethral Resection of Bladder Tumor 2 g (1 g) in bags; table magazine . Method of production of drugs: powder for Mr injection and infusion of 40 mg vial., Tab., Coated tablets, 20 mg, by 40 mg.